Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novartis
Company Monitoring Page for Novartis
latest headlines for company on cafepharma
Novartis Unveils Path to Becoming a Top 5 US Player by 2027
BioSpace
Thu, 09/22/22 - 11:17 pm
Tags:
Novartis
Facing 'imminent' Gilenya generics and a $300M sales hit, Novartis takes patent fight to Supreme Court
Fierce Pharma
Wed, 09/21/22 - 08:02 pm
Tags:
Novartis
,
Supreme Court
,
Gilenya
,
patents
,
legal
,
MS
Unsealed documents detail Biogen's fight against Sandoz Tysabri biosimilar
Endpoints
Tue, 09/20/22 - 08:36 pm
Tags:
Biogen
,
Novartis
,
Sandoz
,
biosimilars
,
Tysabri
,
MS
,
multiple sclerosis
Sandoz reports data from Phase I/III trial of denosumab for osteoporosis
Clinical Trials Arena
Tue, 09/20/22 - 10:07 am
Tags:
Novartis
,
Sandoz
,
clinical trials
,
biosimilarts
,
denosumab
,
osteoporosis
Novartis investing US$300m in next generation biotherapeutics development
Biopharma Reporter
Mon, 09/19/22 - 09:14 am
Tags:
Novartis
,
biologics
,
biotherapeutics
,
drug development
Novartis headquarters raided in Swiss competition authority's patent probe
Fierce Pharma
Thu, 09/15/22 - 10:54 am
Tags:
Novartis
,
Switzerland
,
patents
,
competition
Novartis dodges Gilenya kickback claims—again—after whistleblower lawsuit dismissed
Fierce Pharma
Wed, 09/14/22 - 08:04 pm
Tags:
Novartis
,
whistleblowers
,
whistleblower lawsuit
,
Gilenya
,
kickbacks
,
MS
Novartis touts Cosentyx win in debilitating skin condition. Can it challenge AbbVie's Humira?
Fierce Pharma
Tue, 09/13/22 - 08:03 pm
Tags:
Novartis
,
FDA
,
Cosentyx
,
AbbVie
,
Humira
,
hidradenitis suppurativa
Novartis funnels $300M into early biologic drug manufacturing
BioPharma Dive
Mon, 09/12/22 - 11:36 pm
Tags:
Novartis
,
biologics
,
drug manufacturing
,
Slovenia
,
Austria
ESMO 2022 – the new liver cancer entrants line up
EP Vantage
Thu, 09/8/22 - 10:39 am
Tags:
ESMO
,
liver cancer
,
Keytruda
,
tislelizumab
,
camrelizumab
,
Merck
,
BeiGene
,
Novartis
Novartis' Entresto infringes on university patents, lawsuit claims
Endpoints
Wed, 08/31/22 - 10:29 am
Tags:
Novartis
,
Entresto
,
legal
,
patents
Backed by Medicxi, Novartis vets launch rare blood disorder biotech with fresh take on drug class used in cancers
Endpoints
Sun, 08/28/22 - 10:10 pm
Tags:
Novartis
,
AKT inhibitors
,
Vaderis Therapeutics
,
Medicxi
Novartis cuts manufacturing jobs, closes North Carolina plant ahead of Sandoz spinoff
Fierce Pharma
Fri, 08/26/22 - 10:45 am
Tags:
Novartis
,
drug manufacturing
,
Sandoz
,
generics
Revealed: which pharma companies leading the way in artificial intelligence
Clinical Trials Arena
Fri, 08/26/22 - 10:37 am
Tags:
artificial intelligence
,
Pfizer
,
Novartis
,
AstraZeneca
,
Johnson & Johnson
,
Bristol Myers Squibb
,
Takeda
,
GSK
,
Bayer
,
Astellas
It's a spinoff: Novartis parts ways with Sandoz just as its generics biz shows signs of recovery
Fierce Pharma
Thu, 08/25/22 - 11:30 am
Tags:
spinoffs
,
Novartis
,
Sandoz
,
generics
Safety worries spur Novartis to suspend drug dosing in Huntington’s trial
BioPharma Dive
Thu, 08/25/22 - 11:29 am
Tags:
Novartis
,
Huntington's disease
,
clinical trials
,
branaplam
Merck backs radiopharmaceutical startup Aktis, joining other high-profile backers
BioPharma Dive
Thu, 08/25/22 - 10:55 am
Tags:
Aktis Oncology
,
radiopharmaceuticals
,
Merck
,
Novartis
,
Bristol Myers Squibb
Third Harmonic, with an old Novartis drug in hand, braves frosty IPO waters in a quick-fire cash grab
Fierce Biotech
Wed, 08/24/22 - 10:40 pm
Tags:
Third Harmonic Bio
,
IPOs
,
Novartis
,
allergies
,
inflammatory diseases
Vaderis Forms to Tackle Vascular Malformations with Novartis Vet at the Helm
BioSpace
Mon, 08/22/22 - 10:24 am
Tags:
Vaderis
,
Novartis
,
vascular malformations
,
clinical trials
,
VAD044
Novartis' MS drug Gilenya could inspire new chronic kidney disease treatment
Fierce Biotech
Fri, 08/19/22 - 10:47 am
Tags:
Novartis
,
Gilenya
,
kidney disease
,
chronic kidney disease
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.